Stories from Toyoake · Japan

Fujita Health University is investigating the efficacy of curcumin and sulforaphane as a new treatment for schizophrenia. A new drug, LB-102 (N-methyl amisulpride), has shown promise in treating acute schizophrenia during a 28-day double-blind trial. The study was published in JAMA Psychiatry.